Molecular classification of IDH-mutant glioblastomas based on gene expression profiles

by Wu, Fan, Chai, Rui-Chao, Wang, Zhiliang, Liu, Yu-Qing, Zhao, Zheng, Li, Guan-Zhang, Jiang, Hao-Yu
Published in Carcinogenesis (2019)

Prognostic power of a lipid metabolism gene panel for diffuse gliomas

by Wu, Fan, Zhao, Zheng, Chai, Rui‐Chao, Liu, Yu‐Qing, Li, Guan‐Zhang, Jiang, Hao‐Yu, Jiang, Tao
Published in J Cell Mol Med (2019)

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor

by Wang, Zhi-liang, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Wang, Zheng, Zhang, Chuan-bao, Jiang, Tao
Published in Oncoimmunology (2018)

Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma

by Wang, Zhi-liang, Wang, Zheng, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Zhang, Chuan-bao, Jiang, Tao
Published in Front Immunol (2019)

Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes

by Wu, Fan, Liu, Yan-Wei, Li, Guan-Zhang, Zhai, You, Feng, Yue-Mei, Ma, Wen-Ping, Zhao, Zheng, Zhang, Wei
Published in Br J Cancer (2021)

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme

by Chen, Bao-Shi, Wang, Kuan-Yu, Yu, Shu-Qing, Zhang, Chuan-Bao, Li, Guan-Zhang, Wang, Zhi-Liang, Bao, Zhao-Shi
Published in Oncol Lett (2020)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression

by Liu, Han-jie, Hu, Hui-min, Li, Guan-zhang, Zhang, Ying, Wu, Fan, Liu, Xiu, Wang, Kuan-yu, Zhang, Chuan-bao, Jiang, Tao
Published in Front Cell Dev Biol (2020)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas

by Chang, Yu-Zhou, Li, Guan-Zhang, Pang, Bo, Zhang, Ke-Nan, Zhang, Xiao-Hui, Wang, Yong-Zhi, Jiang, Zhong-li, Chai, Rui-Chao
Published in Front Cell Dev Biol (2020)

ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

by Zhao, Zheng, Zhang, Ke-Nan, Chai, Rui-Chao, Wang, Kuan-Yu, Huang, Ruo-Yu, Li, Guan-Zhang, Wang, Yong-Zhi, Chen, Jing, Jiang, Tao
Published in Dis Markers (2019)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas

by Zhao, Zheng, Li, Guan‐Zhang, Liu, Yu‐Qing, Huang, Ruo‐Yu, Wang, Kuan‐Yu, Jiang, Hao‐Yu, Li, Ren‐Peng, Chai, Rui‐Chao, Zhang, Chuan‐Bao, Wu, Fan
Published in J Cell Mol Med (2020)

Classification of diffuse lower‐grade glioma based on immunological profiling

by Wu, Fan, Wang, Zhi‐Liang, Wang, Kuan‐Yu, Li, Guan‐Zhang, Chai, Rui‐Chao, Liu, Yu‐Qing, Jiang, Hao‐Yu, Zhai, You, Feng, Yue‐Mei, Zhao, Zheng, Zhang, Wei
Published in Mol Oncol (2020)

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma

by Chai, Rui-Chao, Li, Yi-Ming, Zhang, Ke-Nan, Chang, Yu-Zhou, Liu, Yu-Qing, Zhao, Zheng, Wang, Zhi-Liang, Chang, Yuan-Hao, Li, Guan-Zhang, Wang, Kuan-Yu, Wu, Fan, Wang, Yong-Zhi
Published in JCI Insight (2019)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

by Li, Guan-Zhang, Zhang, Ke-Nan, Wang, Zheng, Hu, Hui-Min, Wang, Zhi-Liang, Huang, Ruo-Yu, Jiang, Hao-Yu, Zhai, You, Feng, Yue-Mei, Chang, Yuan-Hao, Li, Ren-Peng, Wu, Fan, Zeng, Fan, Jiang, Tao, Zhang, Wei
Published in Onco Targets Ther (2019)